Decent write up on TIS
"Tissue Therapies is positioned to take advantage of the growing diabetic, venous and pressure ulcers market with their ground breaking VitroGro treatment. commercialisation of VitroGro will significantly de-risk the company while providing analysts with certainty for re-ratings."
link
Might buy in the next few weeks, can see it moving higher on news.